Skip to content

Current Debt at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$2.31B-35.1%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$350M+4.2%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$0-100%
Nuvation Bio logo
Nuvation BioNUVB
$5.79M+1.8%
Tenet Healthcare logo
Tenet HealthcareTHC
$81M-8.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue-
Operating income-$11.4M+27.5%
Net income-$10.8M+27.5%
EPS (diluted)-$0.11+35.3%

Balance sheet

See full
Cash & equivalents$10.0M-3.4%
Total debt$12.3M-9.2%
Total equity$57.9M-22.8%
Total assets$79.7M-18.1%

Cash flow

See full
Operating cash flow-$12.5M+18.8%
CapEx$138.0K
Free cash flow-$12.7M+17.9%

Valuation

See full
Market cap$1.14B+20.6%
Enterprise value$1.14B
P/S6,001×

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-105.3%+50.6pp
Debt / equity0.2×0.0×
Current ratio5.8×-2.0×

Where this comes from

Reported directly by Ethos Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.

The official record: Ethos Technologies, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ethos Technologies, Inc. 's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ethos Technologies, Inc. 's current debt?
Ethos Technologies, Inc. (LIFE) reported current debt of $596K in Q1 2026.
How has Ethos Technologies, Inc. 's current debt changed year-over-year?
Ethos Technologies, Inc. 's current debt increased by 8.4% year-over-year, from $550K to $596K.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.